MR-guided stereotactic body radiation therapy for primary cardiac sarcomas.

ABSTRACT:

Background

Primary cardiac tumors are an extremely rare disease with limited prognosis. The treatment of choice is surgery. Other treatment options include chemotherapy and radiation therapy, which historically represented a palliative approach in patients who were not eligible for surgery. The development of hybrid MR-guided radiation therapy makes it possible to better visualize cardiac lesions and to apply high doses per fraction in sensible organs such as the heart.

Case presentation

Patients affected by inoperable primary cardiac sarcomas and treated at two different institutions were considered for this analysis and retrospectively analyzed. All patients were treated using a 0.35 T hybrid MR Linac system (MRIdian, ViewRay Inc., Mountain View, CA). In the present study

SUBMITTER: Corradini S 

PROVIDER: S-EPMC7995725 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature